About Us
We are committed to the development of non-immunosuppressive small molecule therapies for treatment of inflammatory diseases
Our world class team has 2 decades of intestinal epithelial barrier expertise combined with a track record of success spanning over 35 INDs and 6 commercial products
Team
Miro Brajenovic, PhD
Chief Executive Officer
Roman Sakowicz, PhD
Chief Technology Officer, Head of Discovery
Vallen Graham, PhD
Co-founder, Head of Research
Petr Jansa, PhD
Head of Medicinal Chemistry
Nargis Kohgadai
Associate Scientist
Naomi Vinod
Research Associate intern
Scientific Advisory Board
Jerrold Turner, MD, PhD
Co-founder
Bruce Sands, MD
Clinical Advisor
Stefan Schreiber, MD, PhD
Clinical Advisor
Careers
Research Associate
Senior Research Associate
Scientist/Senior Scientist
Contact
Email:
info@theliumtx.com